Oncology nurses can educate patients on the benefits of subcutaneous administration, including reduced time in the infusion ...

Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient ...

The FDA has accepted Eisai and Biogen’s biologics license application for a monthly infusion of IV Leqembi to treat ...

Biogen and Eisai have announced that the US Food and Drug Administration (FDA) has accepted a Biologics License Application ...

About the Insignis Infusion System The Insignis Syringe Infusion System is a robust, non-electric device designed for routine ...

Incyte (INCY) and Syndax Pharmaceuticals (SNDX) announced that the U.S. Food and Drug Administration has approved Niktimvo ...

Omvoh is the first biologic treatment in more than 15 years to have disclosed two-year Phase 3 efficacy data in Crohn's disease at the time of approval. 2 "The burden of Crohn's disease on patients' ...

Mediplus has launched its latest innovation, the 5-Way TIVA Set, designed to streamline total intravenous anaesthesia (TIVA) ...

The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute ...

A Cleveland Clinic psychiatrist discusses what the latest research suggests causes bipolar, what the individual experiences, ...

A mum-of-three was “shocked” to discover she was suffering from stage four bowel cancer - after doctors told her she had a urine infection.